Biocon Biologics gains UK approval for Vevzuo and Evfraxy, Denosumab Biosimilars EP News Bureau Jul 7, 2025 Vevzuo is authorised for the prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord…
EU approves Biocon Biologics’ Denosumab biosimilars EP News Bureau Jul 3, 2025 Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (Receptor Activator of Nuclear Factor…
